Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | COL6A6 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | MCAT | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
mRNA | MLF1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | SNW1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | RHEB | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | MAF1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
mRNA | GDF6 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | NDP | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | CECR6 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
mRNA | CTIF | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |